College of Agricultural Sciences

W. H. Bisson, Amedei, A., Memeo, L., Forte, S., and Felsher, D. W., “Tumor-Promoting/Associated Inflammation and the Microenvironment: A State of the Science and New Horizons”, Hoboken, NJ, USA: John Wiley & Sons, Inc., 2018, pp. 473 - 510.

C. A. Larsen, Bisson, W. H., and Dashwood, R. H., “Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies”, Journal of medicinal chemistry, vol. 52, pp. 6543–6545, 2009.

C. A. Larsen, Dashwood, R. H., and Bisson, W. H., “Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance”, Pharmacological Research, vol. 62, pp. 457–464, 2010.

A. K. Ehrlich, Pennington, J. M., Bisson, W. H., Kolluri, S., and Kerkvliet, N. I., “TCDD, FICZ, and other high affinity AhR ligands dose-dependently determine the fate of CD4+ T cell differentiation.”, Toxicol Sci, 2018.

J. D. Chavez, Bisson, W. H., and Maier, C. S., “A targeted mass spectrometry-based approach for the identification and characterization of proteins containing $\alpha$-aminoadipic and $\gamma$-glutamic semialdehyde residues”, Analytical and bioanalytical chemistry, vol. 398, pp. 2905–2914, 2010.

H. Schedel, Quaedflieg, P. J. L. M., Broxterman, Q. B., Bisson, W. H., Duchateau, A. L. L., Maes, I. C. H., Herzschuh, R., and Burger, K., “Synthesis of (R)-4, 4, 4-trifluoro-2-mercaptobutyric acid”, Tetrahedron: Asymmetry, vol. 11, pp. 2125–2131, 2000.

S. Tardy, Orsato, A., Mologni, L., Bisson, W. H., Donadoni, C., Gambacorti-Passerini, C., Scapozza, L., Gueyrard, D., and Goekjian, P. G., “Synthesis and biological evaluation of benzo [4, 5] imidazo [1, 2-c] pyrimidine and benzo [4, 5] imidazo [1, 2-a] pyrazine derivatives as anaplastic lymphoma kinase inhibitors”, Bioorganic & medicinal chemistry, vol. 22, pp. 1303–1312, 2014.

L. Mu, Drandarov, K., Bisson, W. H., Schibig, A., Wirz, C., P Schubiger, A., and Westera, G., “Synthesis and binding studies of epibatidine analogues as ligands for the nicotinic acetylcholine receptors”, European journal of medicinal chemistry, vol. 41, pp. 640–650, 2006.

I. A. Murray, Flaveny, C. A., Chiaro, C. R., Sharma, A. K., Tanos, R. S., Schroeder, J. C., Amin, S. G., Bisson, W. H., Kolluri, S., and Perdew, G. H., “Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3′, 4′-dimethoxy-$\alpha$-naphthoflavone”, Molecular pharmacology, vol. 79, pp. 508–519, 2011.

Y. Zhang, Yan, T., Sun, D., Xie, C., Zheng, Y., Zhang, L., Yagai, T., Krausz, K. W., Bisson, W. H., Yang, X., and Gonzalez, F. J., “Structure-activity relationships of the main bioactive constituents of Euodia ruticarpa on aryl hydrocarbon receptor activation and bile acid homeostasis”, Drug Metabolism and Disposition, p. dmd.117.080176, 2018.

A. Perkins, Phillips, J. Lynne, Kerkvliet, N., Tanguay, R., Perdew, G., Kolluri, S., and Bisson, W. H., “A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain”, Biology, vol. 399, no. 4, pp. 645 - 669, 2014.

A. Perkins, Phillips, J. Lynne, Kerkvliet, N. I., Tanguay, R., Perdew, G. H., Kolluri, S., and Bisson, W. H., “A structural switch between agonist and antagonist bound conformations for a ligand-optimized model of the human aryl hydrocarbon receptor ligand binding domain”, Biology, vol. 3, pp. 645–669, 2014.

A. Perkins, Phillips, J. Lynne, Kerkvliet, N. I., Tanguay, R. L., Perdew, G. H., Kolluri, S. K., and Bisson, W. H., “A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain.”, Biology (Basel), vol. 3, no. 4, pp. 645-69, 2014.

A. Dehner, Planker, E., Gemmecker, G., Broxterman, Q. B., Bisson, W. H., Formaggio, F., Crisma, M., Toniolo, C., and Kessler, H., “Solution Structure, Dimerization, and Dynamics of a Lipophilic $\alpha$/310-Helical, C$\alpha$-Methylated Peptide. Implications for Folding of Membrane Proteins”, Journal of the American Chemical Society, vol. 123, pp. 6678–6686, 2001.

J. D. Chavez, Wu, J., Bisson, W. H., and Maier, C. S., “Site-specific proteomic analysis of lipoxidation adducts in cardiac mitochondria reveals chemical diversity of 2-alkenal adduction”, Journal of proteomics, vol. 74, pp. 2417–2429, 2011.

S. Raduner, Bisson, W. H., Abagyan, R., Altmann, K. - H., and Gertsch, J., “Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amides”, Journal of natural products, vol. 70, pp. 1010–1015, 2007.

W. Engström, Darbre, P., Eriksson, S., Gulliver, L., Hultman, T., Karamouzis, M. V., Klaunig, J. E., Mehta, R., Moorwood, K., Sanderson, T., and Bisson, W. H., “The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling”, Carcinogenesis, vol. 36, pp. S38–S60, 2015.

M. J. Nemec, Kim, H., Marciante, A. B., Barnes, R. C., Hendrick, E. D., Bisson, W. H., Talcott, S. T., and Mertens-Talcott, S. U., “Polyphenolics from mango (Mangifera indica L.) suppress breast cancer ductal carcinoma in situ proliferation through activation of AMPK pathway and suppression of mTOR in athymic nude mice.”, J Nutr Biochem, vol. 41, pp. 12-19, 2016.

C. V. Gerlach, Das, S. R., Volz, D. C., Bisson, W. H., Kolluri, S. K., and Tanguay, R. L., “Mono-substituted isopropylated triaryl phosphate, a major component of Firemaster 550, is an AHR agonist that exhibits AHR-independent cardiotoxicity in zebrafish.”, Aquat Toxicol, vol. 154, pp. 71-9, 2014.

C. V. Gerlach, Das, S. R., Volz, D. C., Bisson, W. H., Kolluri, S., and Tanguay, R., “Mono-substituted isopropylated triaryl phosphate, a major component of Firemaster 550, is an AHR agonist that exhibits AHR-independent cardiotoxicity in zebrafish”, Aquatic Toxicology, vol. 154, pp. 71–79, 2014.

C. V. Gerlach, Das, S. R., Volz, D. C., Bisson, W. H., Kolluri, S., and Tanguay, R. L., “Mono-substituted isopropylated triaryl phosphate, a major component of Firemaster 550, is an AHR agonist that exhibits AHR-independent cardiotoxicity in zebrafish”, Aquatic Toxicology, vol. 154, pp. 71 - 79, 2014.

W. H. Bisson, Abagyan, R., and Cavasotto, C. N., “Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations”, Journal of Molecular Graphics and Modelling, vol. 27, no. 4, pp. 452 - 458, 2008.

W. H. Bisson, Koch, D. C., O'Donnell, E. F., Khalil, S. M., Kerkvliet, N. I., Tanguay, R. L., Abagyan, R., and Kolluri, S. Kumar, “Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands”, Journal of medicinal chemistry, vol. 52, pp. 5635–5641, 2009.

W. H. Bisson, Koch, D. C., Donnell, E. F. ’, Khalil, S. M., Kerkvliet, N. I., Tanguay, R. L., Abagyan, R., and Kolluri, S., “Modeling of the Aryl Hydrocarbon Receptor (AhR) Ligand Binding Domain and Its Utility in Virtual Ligand Screening to Predict New AhR Ligands”, Journal of Medicinal Chemistry, vol. 52, no. 18, pp. 5635 - 5641, 2009.

W. H. Bisson, Koch, D. C., O'Donnell, E. F., Khalil, S. M., Kerkvliet, N. I., Tanguay, R. L., Abagyan, R., and Kolluri, S. Kumar, “Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands.”, J Med Chem, vol. 52, no. 18, pp. 5635-41, 2009.